Enhabit, Inc. (NYSE:EHAB – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday after Deutsche Bank Aktiengesellschaft upgraded the stock to a buy rating. The company traded as high as $11.27 and last traded at $10.90, with a volume of 96049 shares trading hands. The stock had previously closed at $10.19.
Several other equities analysts have also commented on EHAB. Wolfe Research set a $12.00 price target on shares of Enhabit in a research note on Thursday, January 8th. UBS Group raised shares of Enhabit from a “neutral” rating to a “buy” rating and upped their price target for the stock from $8.50 to $12.00 in a research report on Thursday. Truist Financial set a $10.50 price target on shares of Enhabit and gave the company a “hold” rating in a report on Wednesday, January 7th. Citigroup restated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Finally, Cowen raised Enhabit to a “buy” rating in a research note on Tuesday. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $11.63.
Check Out Our Latest Stock Analysis on Enhabit
Hedge Funds Weigh In On Enhabit
Enhabit Price Performance
The company’s 50-day moving average price is $9.05 and its two-hundred day moving average price is $8.21. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.58 and a quick ratio of 1.58. The company has a market capitalization of $548.88 million, a P/E ratio of -43.20 and a beta of 1.66.
Enhabit (NYSE:EHAB – Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The firm had revenue of $263.60 million during the quarter, compared to the consensus estimate of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Further Reading
- Five stocks we like better than Enhabit
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
